Where We Are
What We Do
Industries We Serve
Pharmaceuticals
Global Regulatory Partners Inc. (GRP) provides hands-on regulatory affairs services to pharmaceutical, biologic and generic drug companies. The GRP regulatory team has many years of experience helping companies develop and register their products in different markets in compliance with local regulations, in record time, and with minimal risk. Services provided by GRP include, but are not limited to, Regulatory Intelligence, Regulatory Strategy, Consultation Meetings with Health Authorities, Regulatory Operations, Clinical Trial Operations, Medical Writing and Publishing, Product Registration, and Product Life-Cycle Management.,
Medical Devices
GRP provides hands-on regulatory affairs services to pharmaceutical, biologic and generic drug companies. The GRP regulatory team has many years of experience helping companies develop and register their products in different markets in compliance with local regulations, in record time, and with minimal risk. Services provided by GRP include, but are not limited to, Regulatory Intelligence, Regulatory Strategy, Consultation Meetings with Health Authorities, Regulatory Operations, Clinical Trial Operations, Medical Writing and Publishing, Product Registration, and Product Life-Cycle Management.
Cosmetics
GRP offers a comprehensive range of services for Cosmetics and Personal Care Products (PCP) to cosmetic and nutraceutical companies. GRP’s team of professionals ensure that your products meet the latest safety regulations applicable to your product before being commercialized and used by consumers. GRP cosmetics services include formulation review and assessment, labeling review, product registration (as needed) and post-marketing surveillance.
Nutraceuticals
The global Nutraceutical and Dietary Supplement markets are a rapidly growing due to changing lifestyles, increasing health concerns of consumers and a growing awareness for the need to consume healthful and nutritional foods and food supplements. GRP has a team of experts who help Nutraceutical and Dietary Supplement companies worldwide to register and commercialize their products in compliance with local regulations. GRP services include, but not limited to the review of product formulations, excipient content, nutrient content, labelling, artwork, and health claims.
Pharmacovigilance
GRP provides pharmacovigilance services to Pharmaceutical, Biologic, Medical Device, Nutraceutical and Cosmetic companies worldwide. The GRP pharmacovigilance team members have long standing industry experience and consistently deliver high quality and compliant pharmacovigilance services. These help companies optimize their products’ risk-benefit profile and help improve the safety of patients and consumers.
Quality
The GRP Quality Team has the required skills, experience and certifications to assist pharmaceutical and medical device companies attain and remain in compliance with the required quality standards. The GRP Quality Team helps companies develop or review their quality standard operating procedures (SOPs), implement and maintain an appropriate quality management system (QMS), and manage compliance with applicable GMP, ISO 13485, GCP, CGTP and other quality standards through their products’ life-cycle. GRP has Certified Quality Auditors who can help you prepare for FDA inspections and prepare prompt responses to inspectional observations.
About GRP
Who We Are
We are a consulting company that provides a full spectrum of tailored Regulatory Affairs, Clinical, Quality and Pharmacovigilance Services to pharmaceutical, medical device, cosmetic, and Nutraceutical companies worldwide.
Our main focus is to provide our life science clients with tailored services that meet their business needs, fit their budget and support their strategic growth globally.
From our Blog
China’s CDE Releases guidance for the Technical requirements of Generic injections
China’s CDE releases guidance on the Technical Requirements for Quality and Efficacy Consistency Evaluation of Generic Chemical Injections
Brazil’s ANVISA outlines reasons for the approval and rejection of registration of synthetic drugs.
Anvisa presents the reasons for the approval and rejection do generic drugs and how companies should proceed in order to register successfully with the Health Authority.
Food Supplements in Latin America : Market overview and Regulations
Latin America is becoming a land of opportunity for many emerging markets and Food Supplements are rapidly becoming more popular in the LATAM region.This blog will overview Brazil, Mexico and Argentina Market potential for food supplements and relevant regulation specific to each region.
China’s NMPA announces Delay of Unique Device Identification (UDI) Implementation
Due to the Coronavirus, Chinese Regulatory Authority, National Medical Products administration (NMPA). decided to delay UDI implantation to next year January 2021.
Brazil’s Anvisa updates requirements for Good Distribution and Storage Practices Certification (CBPDA) for Health Products
Anvisa changes the list of documents for Good Distribution and Storage Practices Certification petitions for health products.
Brazil’s Anvisa publishes guide about cyber security in medical devices
Anvisa publishes Guide 38/2020, “Principles and Practices of Cyber Security in Medical Devices”. The document is intended for anyone interested in ensuring the safe use of medical devices and will be useful for users of such equipment, patients, manufacturers, distributors, health services and researchers in the area of safety
